Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries

BACKGROUND: The quadrivalent human papillomavirus (qHPV) vaccine prevented vaccine HPV type-related infection and disease in young women in the 4-year FUTURE II efficacy study (NCT00092534). We report long-term effectiveness and immunogenicity at the end of 14 years of follow-up after enrollment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjaer, Susanne K., Nygård, Mari, Sundström, Karin, Dillner, Joakim, Tryggvadottir, Laufey, Munk, Christian, Berger, Sophie, Enerly, Espen, Hortlund, Maria, Ágústsson, Ágúst Ingi, Bjelkenkrantz, Kaj, Fridrich, Katrin, Guðmundsdóttir, Ingibjorg, Sørbye, Sveinung Wergeland, Bautista, Oliver, Group, Thomas, Luxembourg, Alain, Marshall, J. Brooke, Radley, David, Yang, Yi Shen, Badshah, Cyrus, Saah, Alfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329692/
https://www.ncbi.nlm.nih.gov/pubmed/32637895
http://dx.doi.org/10.1016/j.eclinm.2020.100401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329692/
https://www.ncbi.nlm.nih.gov/pubmed/32637895
http://dx.doi.org/10.1016/j.eclinm.2020.100401

Ejemplares similares